Mundipharma Healthcare Indonesia Appoints Pyridam Farma to Market Betadine Brand in Indonesia
Jakarta, April 5, 2022 - Mundipharma Healthcare Indonesia (MHI), the owner of the Betadine brand in Indonesia, has signed an exclusive cooperation agreement for marketing and promotion services with PT Pyridam Farma Tbk, a public pharmaceutical company in Indonesia with
Merz Therapeutics GmbH Together with Pyridam Farma Presents Innovative Products for the Indonesian Community
Jakarta, 22 March 2022 - Merz Therapeutics GmbH, an affiliate of Merz Pharmaceutical GmbH which excels in neurotoxin field with Pyridam Farma as one of the public Healthcare companies in Indonesia, announced that together they will launch an innovator product
PT Pyridam Farma Tbk Enters into a Marketing and Promotion Services Agreement with Mundhipharma Healthcare Indonesia
Referring to Financial Service Authority (“OJK”) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Facts by Issuer of Public Company and Annex to Regulation I-E of Decree of the Board of Directors of PT Bursa Efek No. Kep. 00015/BEI/01-2021 on